- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05911737
Ocular Parameters in Patients With Sleep Apnea
June 10, 2023 updated by: Georgios Labiris, Democritus University of Thrace
Ocular Parameters Assessment With a Deep Neural Network in Patients With Sleep Apnea
The aim of this study is to assess the ocular parameters of drowsiness in patients with diagnosed Obstructive Sleep Apnea Syndrome through objective methods of ocular imaging and subjective evaluation methods (questionnaire)
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This is a single-center prospective comparative observational study.
One hundred patients with drowsiness that will be examined in the Sleep Clinic of Alexandroupolis University Hospital, aged between18-70 years old, with Distance Uncorrected Visual Acuity ≥ (dUVA): 5/10 will be recruited.
They will be separated into two groups, one consisting of patients with diagnosed Obstructive Sleep Apnea and one without this diagnosis, according to the Epworth Sleepiness Scale - ESS, which is a valid tool for quantifying daily sleepiness.
A 10-minute video in a foreign language (not English or Greek) with greek subtitles will be presented to them and a questionnaire will follow to assess the level of concentration during the video (the subtitles are crucial to understanding the video's plot).
The video will be displayed in a 11.6" screen with resolution of 1920x1080 pixels, at 70 cm patient-to-screen distance.
The patients' eyes will be recorded during the video with a Raspberry Pi Camera Module IR-CUT v2 (5MP,1080p) with 2 IR LED lights, connected to a Raspberry Pi 3 model v1.2, operating at the original resolution of 1080×1920, at 20 cm patient-to-camera distance and an algorithm will be developed to analyze the following parameters: 1.
The complete and incomplete blinks defined by the "length of palpebral fissure-to-iris diameter" ratio, 3. Length of palpebral fissure of both eyes.
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Georgios Labiris, MD, PhD
- Phone Number: 0030 2551030405
- Email: labiris@usa.net
Study Locations
-
-
Evros
-
Alexandroupolis, Evros, Greece, 68100
- Recruiting
- Democritus University of Thrace
-
Contact:
- Georgios Labiris, MD, PhD
- Phone Number: 00302551030990
- Email: labiris@usa.net
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
patients with obstructive sleep apnea and controls (not diagnosed with οbstructive sleep apnea)
Description
Inclusion Criteria:
- patients with obstructive sleep apnea and controls, aged 18-70 years old, with distance uncorrected visual acuity (dUVA) ≥ 5/10.
Exclusion Criteria:
- (dUVA) <5/10,
- intraocular pressure lowering medications
- former corneal or fundus disease
- neurological or psychiatric conditions
- mental disability
- difficulty reading
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients diagnosed with Obstructive Sleep Apnea
|
A 10-minute video in a foreign language (not English or Greek) with greek subtitles will be presented and a questionnaire will follow to assess the level of concentration during the video
|
|
Patients not diagnosed with Obstructive Sleep Apnea
|
A 10-minute video in a foreign language (not English or Greek) with greek subtitles will be presented and a questionnaire will follow to assess the level of concentration during the video
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total number of blinks during the 10-minute video
Time Frame: 1 week
|
The total number of blinks during the 10-minute video.
Complete blinks are defined by the "length of palpebral fissure-to-iris diameter" ratio.
|
1 week
|
|
Total number of complete blinks during the 10-minute video
Time Frame: 1 week
|
The total number of complete blinks during the 10-minute video.
Complete blinks are defined by the "length of palpebral fissure-to-iris diameter" ratio.
|
1 week
|
|
Total number of incomplete blinks during the 10-minute video
Time Frame: 1 week
|
The total number of incomplete blinks during the 10-minute video.
Incomplete blinks are defined by the "length of palpebral fissure-to-iris diameter" ratio.
|
1 week
|
|
Number of total blinks for each minute
Time Frame: 1 week
|
Number of total blinks for each minute of the 10-minute video
|
1 week
|
|
Number of complete blinks for each minute
Time Frame: 1 week
|
Number of complete blinks for each minute of the 10-minute video
|
1 week
|
|
Number of incomplete blinks for each minute
Time Frame: 1 week
|
Number of incomplete blinks per minute for each minute of the 10-minute video
|
1 week
|
|
Total blinks per minute
Time Frame: 1 week
|
Total blinks per minute during the 10-minute video
|
1 week
|
|
Complete blinks per minute
Time Frame: 1 week
|
Complete blinks per minute during the 10-minute video
|
1 week
|
|
Incomplete blinks per minute
Time Frame: 1 week
|
Incomplete blinks per minute during the 10-minute video
|
1 week
|
|
Length of palpebral fissure of both eyes
Time Frame: 1 week
|
The distance between the upper eyelid margin and the lower eyelid margin (ie. the vertical dimension of the palpebral fissure) for each frame
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fixations to the area of interest
Time Frame: 1 week
|
Number of fixations to the area of interest (subtitles)
|
1 week
|
|
Fixation duration
Time Frame: 1 week
|
Mean fixation duration (duration of fixation per video per participant)
|
1 week
|
|
Reading time
Time Frame: 1 week
|
The absolute reading time (the sum of the duration of all fixations and saccadic movements in the area of focus starting from the first fixation)
|
1 week
|
|
Participant's dedication time to the area of focus
Time Frame: 1 week
|
The percentage of time that each participant dedicates to the area of focus depending on the time of subtitle exposure (eg.
subtitle reading time/overall subtitle exposure= 2500 msec/3000 msec=83%)
|
1 week
|
|
Rereadings
Time Frame: 1 week
|
Rereadings: the number of fixations/seccadic movements to the area of focus after the first reading (indicating of subtitlte interpretation difficulty or extended subtitle exposure time).
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Georgios Labiris, MD, PhD, Democritus University of Thrace
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2022
Primary Completion (Estimated)
February 1, 2024
Study Completion (Estimated)
July 1, 2024
Study Registration Dates
First Submitted
June 10, 2023
First Submitted That Met QC Criteria
June 10, 2023
First Posted (Actual)
June 22, 2023
Study Record Updates
Last Update Posted (Actual)
June 22, 2023
Last Update Submitted That Met QC Criteria
June 10, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ES2/Th35/27-02-2020
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Concentration Ability Impaired
-
Federal State Budgetary Scientific Institution...Russian Science Foundation; Group of companies EFKOCompletedCognitive Change | Emotional Regulation | Concentration Ability Impaired | Memory; Disturbance, MildRussian Federation
-
JoySpringCitruslabsCompletedMental Fatigue | Concentration Ability ImpairedUnited States
-
American University of Beirut Medical CenterCompletedNoise Exposure | Nurse's Role | Surgical Procedure, Unspecified | Concentration Ability Impaired | Performance Anxiety | Physician's RoleLebanon
-
Centagen, Inc.CompletedQuality of Life | Stress | Blood Pressure | Joint Instability | Immune Deficiency | Lung Function Decreased | HDL Low | Energy Supply; Deficiency | Concentration Ability ImpairedUnited States
-
Radboud University Medical CenterNot yet recruitingBipolar Disorder | Concentration Ability Impaired | Nephrogenic Diabetes Insipidus | Lithium Toxicities | Lithium - Induced NephropathyNetherlands
-
San Francisco Veterans Affairs Medical CenterRecruitingCOVID-19 | Fatigue | COVID-19 Pandemic | Concentration Ability Impaired | Memory Deficits | Brain Fog | COVID Long-HaulUnited States
-
Massachusetts General HospitalCompletedFasting Glucose | Metformin Response | Tryptophan Concentration | Metformin Concentration | Diet TolerabilityUnited States
-
Hummel, ChristianeLudwig-Maximilians - University of MunichCompleted
-
College of Physicians and Surgeons PakistanRecruitingSerum Calcium ConcentrationPakistan
-
University of Arkansas, FayettevilleCompletedSweat Sodium ConcentrationUnited States
Clinical Trials on Short video and Questionnaire
-
University Hospital FreiburgStanford University; Heidelberg UniversityNot yet recruitingPsychological Capital
-
Stanford UniversityAlexander von Humboldt Association; Stanford Center for Digital HealthCompletedSocial Stigma Towards People With AddictionUnited States
-
Tarsus UniversityCompletedPain | Satisfaction | Anxiety and FearTurkey (Türkiye)
-
Tarsus UniversityCompletedAnxiety | Fear | Satisfaction | Children, OnlyTurkey (Türkiye)
-
University Hospital FreiburgStanford University; Heidelberg UniversityNot yet recruitingCardiovascular Risk Factor | Sodium Excess | Education Entertainment Intervention | Short, Animated Storytelling
-
London School of Hygiene and Tropical MedicineCompletedInformation Seeking BehaviorUnited Kingdom
-
National Taiwan University HospitalUnknownNursing | PsychiatryTaiwan
-
Stanford UniversityHeidelberg Institute of Global Health, Heidelberg University, GermanyNot yet recruitingColorectal Cancer ScreeningUnited States
-
Leiden University Medical CenterRecruiting
-
Research Foundation for Mental Hygiene, Inc.CompletedBrief Video-based Intervention | Vignette Based Intervention | Non Intervention Control ArmUnited States